These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 21549765

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Endocannabinoid analogues exacerbate marble-burying behavior in mice via TRPV1 receptor.
    Umathe SN, Manna SS, Jain NS.
    Neuropharmacology; 2012 Apr; 62(5-6):2024-33. PubMed ID: 22248639
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Regulation of subthalamic neuron activity by endocannabinoids.
    Morera-Herreras T, Ruiz-Ortega JA, Taupignon A, Baufreton J, Manuel I, Rodriguez-Puertas R, Ugedo L.
    Synapse; 2010 Sep; 64(9):682-98. PubMed ID: 20336631
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Facilitation of CB1 receptor-mediated neurotransmission decreases marble burying behavior in mice.
    Gomes FV, Casarotto PC, Resstel LB, Guimarães FS.
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar 30; 35(2):434-8. PubMed ID: 21111767
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy.
    Khasabova IA, Khasabov S, Paz J, Harding-Rose C, Simone DA, Seybold VS.
    J Neurosci; 2012 May 16; 32(20):7091-101. PubMed ID: 22593077
    [Abstract] [Full Text] [Related]

  • 14. Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys.
    Schindler CW, Scherma M, Redhi GH, Vadivel SK, Makriyannis A, Goldberg SR, Justinova Z.
    Psychopharmacology (Berl); 2016 May 16; 233(10):1867-77. PubMed ID: 26803499
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Acute effects of endocannabinoid anandamide and CB1 receptor antagonist, AM251 in the regulation of thyrotropin secretion.
    da Veiga MA, Fonseca Bloise F, Costa-E-Sousa RH, Souza LL, Almeida NA, Oliveira KJ, Pazos-Moura CC.
    J Endocrinol; 2008 Nov 16; 199(2):235-42. PubMed ID: 18755884
    [Abstract] [Full Text] [Related]

  • 17. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
    Desroches J, Charron S, Bouchard JF, Beaulieu P.
    Neuropharmacology; 2014 Feb 16; 77():441-52. PubMed ID: 24148808
    [Abstract] [Full Text] [Related]

  • 18. Effects of endocannabinoid neurotransmission modulators on brain stimulation reward.
    Vlachou S, Nomikos GG, Panagis G.
    Psychopharmacology (Berl); 2006 Oct 16; 188(3):293-305. PubMed ID: 16953388
    [Abstract] [Full Text] [Related]

  • 19. Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses.
    Batista LA, Bastos JR, Moreira FA.
    J Psychopharmacol; 2015 Mar 16; 29(3):335-43. PubMed ID: 25601395
    [Abstract] [Full Text] [Related]

  • 20. Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors.
    Sartim AG, Guimarães FS, Joca SR.
    Behav Brain Res; 2016 Apr 15; 303():218-27. PubMed ID: 26801828
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.